肥胖
肠道菌群
机制(生物学)
药品
生物
生物信息学
化学
生物技术
生物化学
药理学
内分泌学
认识论
哲学
作者
Yongjian Liu,Jiajia Chen,Qiuhua Tan,Xiaoyi Deng,Ping-Ju Tsai,Pei-Hsuan Chen,Manxiang Ye,Jiao Guo,Zhixing Su
标识
DOI:10.1021/acs.jafc.9b06079
摘要
Obesity has an important influence on health conditions, causing a multitude of complications and comorbidities, and drug therapy is considered to be one of the treatment strategies. Nowadays, there is increasing interest in the study of intestinal microbiota regulation of obesity; also, an increasing number of agricultural and sideline products have been found to have anti-obesity potential. In the present review, we summarize an overview of current known and potential anti-obesity oligosaccharides and their molecular structures. We describe their anti-obesity potential activity and the molecular structure associated with this activity, the regulation of intestinal microbiota composition and its mechanism of action, including regulation of the short-chain fatty acid (SCFA) pathway and altering bile acid (BA) pathway. This review will provide new ideas for us to develop new anti-obesity functional foods.
科研通智能强力驱动
Strongly Powered by AbleSci AI